BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
BRISTOL MYERS SQUIBB CO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$58.83−0.92 (-1.54%)
Close on Oct 19, 2026
- Market cap
- $120.48B
- P/E (TTM)
- 13.0
- Dividend yield
- 4.23%
BRISTOL MYERS SQUIBB CO balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 70.2%
- Operating margin
- –
- Net margin
- 18.9%
- Return on equity, FY2025
- 40.5%
Financial strength
- Current ratio
- 1.53
- Debt to equity
- 1.93
- Debt to assets
- 49.2%
- Cash to current liabilities
- 46.7%
Valuation
- P/E ratio
- 13.0
- Price to sales
- 2.45
- Price to book
- 5.40
- Dividend yield
- 4.23%